What is the best strategy for treating TB-HIV co-infected patients with HAART and rifampicin without saquinavir?

Detalhes bibliográficos
Autor(a) principal: Torres, Thiago S.
Data de Publicação: 2007
Outros Autores: Rolla, Valéria C.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da FIOCRUZ (ARCA)
Texto Completo: https://www.arca.fiocruz.br/handle/icict/57017
Resumo: Fundação Oswaldo Cruz. Instituto de Pesquisa Clínica Evandro Chagas. Rio de Janeiro, RJ, Brasil.
id CRUZ_3b4331d86b58346b9d1a7586bf099bae
oai_identifier_str oai:www.arca.fiocruz.br:icict/57017
network_acronym_str CRUZ
network_name_str Repositório Institucional da FIOCRUZ (ARCA)
repository_id_str 2135
spelling Torres, Thiago S.Rolla, Valéria C.2023-02-11T01:36:12Z2023-02-11T01:36:12Z2007TORRES, Thiago S. ; ROLLA, Valéria C. What is the best strategy for treating TB-HIV co-infected patients with HAART and rifampicin without saquinavir? The international Journal of Tuberculosis and Lung Disease, v. 11, n. 8, p. 933-934, 2007.1027-3719https://www.arca.fiocruz.br/handle/icict/57017engIngenta ConnectWhat is the best strategy for treating TB-HIV co-infected patients with HAART and rifampicin without saquinavir?info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleTuberculosisDiseaseTB-HIVHAARTRifampicinFundação Oswaldo Cruz. Instituto de Pesquisa Clínica Evandro Chagas. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto de Pesquisa Clínica Evandro Chagas. Rio de Janeiro, RJ, Brasil.info:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZORIGINALTorres_Thiago_etal_INI_2007.pdfTorres_Thiago_etal_INI_2007.pdfapplication/pdf44910https://www.arca.fiocruz.br/bitstream/icict/57017/2/Torres_Thiago_etal_INI_2007.pdfee312fb45941122721a6b073162bbb21MD52LICENSElicense.txttext/plain1748https://www.arca.fiocruz.br/bitstream/icict/57017/1/license.txt8a4605be74aa9ea9d79846c1fba20a33MD51icict/570172023-02-10 22:39:32.487oai:www.arca.fiocruz.br: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Repositório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352023-02-11T01:39:32Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false
dc.title.en_US.fl_str_mv What is the best strategy for treating TB-HIV co-infected patients with HAART and rifampicin without saquinavir?
title What is the best strategy for treating TB-HIV co-infected patients with HAART and rifampicin without saquinavir?
spellingShingle What is the best strategy for treating TB-HIV co-infected patients with HAART and rifampicin without saquinavir?
Torres, Thiago S.
Tuberculosis
Disease
TB-HIV
HAART
Rifampicin
title_short What is the best strategy for treating TB-HIV co-infected patients with HAART and rifampicin without saquinavir?
title_full What is the best strategy for treating TB-HIV co-infected patients with HAART and rifampicin without saquinavir?
title_fullStr What is the best strategy for treating TB-HIV co-infected patients with HAART and rifampicin without saquinavir?
title_full_unstemmed What is the best strategy for treating TB-HIV co-infected patients with HAART and rifampicin without saquinavir?
title_sort What is the best strategy for treating TB-HIV co-infected patients with HAART and rifampicin without saquinavir?
author Torres, Thiago S.
author_facet Torres, Thiago S.
Rolla, Valéria C.
author_role author
author2 Rolla, Valéria C.
author2_role author
dc.contributor.author.fl_str_mv Torres, Thiago S.
Rolla, Valéria C.
dc.subject.en.en_US.fl_str_mv Tuberculosis
Disease
TB-HIV
HAART
Rifampicin
topic Tuberculosis
Disease
TB-HIV
HAART
Rifampicin
description Fundação Oswaldo Cruz. Instituto de Pesquisa Clínica Evandro Chagas. Rio de Janeiro, RJ, Brasil.
publishDate 2007
dc.date.issued.fl_str_mv 2007
dc.date.accessioned.fl_str_mv 2023-02-11T01:36:12Z
dc.date.available.fl_str_mv 2023-02-11T01:36:12Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.citation.fl_str_mv TORRES, Thiago S. ; ROLLA, Valéria C. What is the best strategy for treating TB-HIV co-infected patients with HAART and rifampicin without saquinavir? The international Journal of Tuberculosis and Lung Disease, v. 11, n. 8, p. 933-934, 2007.
dc.identifier.uri.fl_str_mv https://www.arca.fiocruz.br/handle/icict/57017
dc.identifier.issn.en_US.fl_str_mv 1027-3719
identifier_str_mv TORRES, Thiago S. ; ROLLA, Valéria C. What is the best strategy for treating TB-HIV co-infected patients with HAART and rifampicin without saquinavir? The international Journal of Tuberculosis and Lung Disease, v. 11, n. 8, p. 933-934, 2007.
1027-3719
url https://www.arca.fiocruz.br/handle/icict/57017
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv Ingenta Connect
publisher.none.fl_str_mv Ingenta Connect
dc.source.none.fl_str_mv reponame:Repositório Institucional da FIOCRUZ (ARCA)
instname:Fundação Oswaldo Cruz (FIOCRUZ)
instacron:FIOCRUZ
instname_str Fundação Oswaldo Cruz (FIOCRUZ)
instacron_str FIOCRUZ
institution FIOCRUZ
reponame_str Repositório Institucional da FIOCRUZ (ARCA)
collection Repositório Institucional da FIOCRUZ (ARCA)
bitstream.url.fl_str_mv https://www.arca.fiocruz.br/bitstream/icict/57017/2/Torres_Thiago_etal_INI_2007.pdf
https://www.arca.fiocruz.br/bitstream/icict/57017/1/license.txt
bitstream.checksum.fl_str_mv ee312fb45941122721a6b073162bbb21
8a4605be74aa9ea9d79846c1fba20a33
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
repository.name.fl_str_mv Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)
repository.mail.fl_str_mv repositorio.arca@fiocruz.br
_version_ 1813008849451352064

Registros relacionados